HIGHLIGHTS
- who: Guixia Wei from the Brown University, United States have published the article: Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and Perspectives, in the Journal: (JOURNAL)
- what: Advanced IDSRCT patients with extensive systemic metastases who cannot tolerate surgery or systemic chemotherapy may consider targeted therapy with mild adverse reactions, including TKI inhibitors, mTOR inhibitors, or bevacizumab (53, 59, 68, 121).
- future: Due to the rarity and poor prognosis of this neoplasm further studies are required to propose effective regimens for IDSRCT patients.
SUMMARY
There is a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.